Equity Overview
Price & Market Data
Price: $115.7
Daily Change: -$3.06 / 2.64%
Daily Range: $115.3 - $120.5
Market Cap: $3,945,622,784
Daily Volume: 555,437
Performance Metrics
1 Week: -2.78%
1 Month: -8.50%
3 Months: 20.72%
6 Months: 55.10%
1 Year: -22.09%
YTD: 85.50%
Company Details
Employees: 728
Sector: Health technology
Industry: Medical specialties
Country:
Details
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.